Atlas Trials

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).

Clinical trial NCT00077649 · COMPLETED

Trial details

NCT number
NCT00077649
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2004-01-01
Primary completion
2005-12-01
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.